PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

(+)-Clausenamide protects against drug-induced liver injury by inhibiting hepatocyte ferroptosis

Mouse / Chemical/toxin

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 32951003 ↗2020Reported benefit

(+)-Clausenamide protects against drug-induced liver injury by inhibiting hepatocyte ferroptosis

MouseChemical/toxinC57BL/6MaleIntragastric (oral gavage)50 mg/kg/day (also tested up to 100 mg/kg/day), intragastri…Pretreatment for 7 consecutive days before the APAP or erastin challenge

Model: Acetaminophen (APAP)-induced or erastin-induced drug-induced liver injury

(+)-CLA significantly improved liver function and histopathology, reduced hepatocyte death, reversed GSH depletion, and inhibited lipid peroxidation in both APAP- and erastin-induced liver injury models; mechanistically, (+)-CLA restored GPX4 and SLC7A11 levels, indicating inhibition of ferroptosis…

Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.